Antje Blank

13PUBLICATIONS
20CO-AUTHORS
Molecular targetsPharmacogenomicsVenereologyMedical parasitologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 17, 2024
Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin.

Nicolas Hohmann, Anna S Friedrichs, Jürgen Burhenne

|Feb 23, 2024
Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers.

Brit S Rohr, Evelyn Krohmer, Kathrin I Foerster

|Dec 19, 2023
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin.

Evelyn Krohmer, Brit Silja Rohr, Felicitas Stoll

|Aug 09, 2023
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine.

Micha Rosenkranz, Kristin Fürle, Julia Hibbert

|Jul 28, 2023
CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults.

Amin Muhareb, Antje Blank, Andreas D Meid

|Mar 04, 2023
Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.

Alexander Lenard, Simon A Hermann, Felicitas Stoll

Pageof 3

Frequent Collaborators

7 joint publications

Walter E Haefeli

5 joint publications

Gerd Mikus

4 joint publications

Jürgen Burhenne

3 joint publications

Kathrin I Foerster